Abstract

Intracoronary delivery of extracellular vesicles from human cardiac progenitor cells reduces infarct size in porcine acute myocardial infarction.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Cardiac stem cell therapy: Does a newborn infant's heart have infinite potential for stem cell therapy?
Tatsuo Ito ... Toshikazu Sano
The Journal of Thoracic and Cardiovascular Surgery | VOL. 163
Tatsuo Ito, et. al.Tatsuo Ito ... Toshikazu Sano
14 Sep 2020
Human Cardiac Stem Cells
Annarosa Leri
Circulation | VOL. 120
Annarosa LeriAnnarosa Leri
07 Dec 2009
Different types of cultured human adult cardiac progenitor cells have a high degree of transcriptome similarity.
Alessandro Giacomello ... Elisa Messina
Journal of cellular and molecular medicine | VOL. 18
Alessandro Giacomello, et. al.Alessandro Giacomello ... Elisa Messina
14 Oct 2014
Abstract 65: Latrophilin-2 is a Specific Cell-surface Marker for Cardiac Progenitor Cells and Specifies Cardiac Lineage Commitment and Development
Han-Mo Yang ... Jin-Woo Lee
Circulation Research | VOL. 119
Han-Mo Yang, et. al.Han-Mo Yang ... Jin-Woo Lee
22 Jul 2016
View more papers

More From: European heart journal

Paper Title
Journal
Date
Author
Percutaneous stellate ganglion block for electrical storm treatment: the new rising STAR?
Roberto Scacciavillani
European heart journal | VOL. -
Roberto ScacciavillaniRoberto Scacciavillani
29 May 2024
Percutaneous stellate ganglion block and catheter ablation: not enemies but allies in fighting electrical storm.
Simone Savastano ... Roberto Rordorf
European heart journal | VOL. -
Simone Savastano, et. al.Simone Savastano ... Roberto Rordorf
29 May 2024
Anticoagulation for post-operative atrial fibrillation after isolated coronary artery bypass grafting: a meta-analysis.
Mileen R D Van De Kar ... Luuk C Otterspoor
European heart journal | VOL. -
Mileen R D Van De Kar, et. al.Mileen R D Van De Kar ... Luuk C Otterspoor
29 May 2024
Great Debate: SGLT2 inhibitors should be first-line treatment in heart failure with reduced ejection fraction.
Milton Packer ... Johann Bauersachs
European heart journal | VOL. -
Milton Packer, et. al.Milton Packer ... Johann Bauersachs
28 May 2024
View more papers